id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2022-0001-0591,DEA,DEA-2022-0001,"Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine (4-OH-DiPT), 5-methoxy-alpha-methyltryptamine (5-MeO-AMT), 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT), 5-methoxy-N,N-diethyltryptamine (5-MeO-DET), and N,N-diisopropyltryptamine (DiPT) in Schedule I; Withdrawal and Notice of Hearing",Proposed Rule,,2022-07-27T04:00:00Z,2022,7,2022-07-27T04:00:00Z,,2022-07-27T12:21:18Z,2022-16102,0,0,09000064851ecfe2
DEA-2022-0001-0590,DEA,DEA-2022-0001,"Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine, 5-methoxy-alpha-methyltryptamine, 5-methoxy-N-methyl-N-isopropyltryptamine, 5-methoxy-N,N-diethyltryptamine, and N,N-diisopropyltryptamine in Schedule I",Proposed Rule,,2022-07-06T04:00:00Z,2022,7,2022-07-06T04:00:00Z,,2022-07-07T13:59:19Z,2022-14372,0,0,09000064851b25a1
DEA-2022-0001-0001,DEA,DEA-2022-0001,"Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine, 5-methoxy-alpha-methyltryptamine, 5-methoxy-N-methyl-N-isopropyltryptamine, 5-methoxy-N,N-diethyltryptamine, and N,N-diisopropyltryptamine in Schedule I",Proposed Rule,,2022-01-14T05:00:00Z,2022,1,2022-01-14T05:00:00Z,2022-02-15T04:59:59Z,2022-02-16T02:00:43Z,2022-00713,0,0,0900006484f1fcdd